Last reviewed · How we verify
[14C]HRS9531
At a glance
| Generic name | [14C]HRS9531 |
|---|---|
| Sponsor | Fujian Shengdi Pharmaceutical Co., Ltd. |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- [14C]HRS9531 CI brief — competitive landscape report
- [14C]HRS9531 updates RSS · CI watch RSS
- Fujian Shengdi Pharmaceutical Co., Ltd. portfolio CI